TB-500, also known as Thymosin Beta-4 (Tβ4), is a naturally occurring peptide found in virtually all human and animal cells. It has generated significant interest in the research community due to its role in actin regulation, cell migration, and tissue repair signaling. This guide covers what researchers need to know about TB-500 from a scientific standpoint.
What Is TB-500?
TB-500 is a synthetic version of a naturally occurring 43-amino acid peptide fragment derived from Thymosin Beta-4. The specific active sequence — LKKTETQ — is believed to be responsible for many of its biological effects, particularly in promoting actin polymerization and cellular motility.
Thymosin Beta-4 is present in high concentrations in platelets, white blood cells, and wound secretions — consistent with its proposed role in tissue repair and immune modulation. Research in cell cultures and animal models has explored its effects on wound healing, inflammation, and angiogenesis.
Free Tool
Peptide Reconstitution Calculator
Convert vial strength, water volume, and desired dose into precise syringe units. Works for BPC-157, TB-500, GHK-Cu, and all research peptides.
Try the Calculator →TB-500 Mechanism of Action
TB-500 functions primarily by binding to actin, the protein that forms the cytoskeleton of cells. By sequestering G-actin monomers, TB-500 regulates the ratio of free to filamentous actin, which influences cell migration, proliferation, and differentiation.
Key pathways under investigation include upregulation of cell-building proteins, reduced inflammation via NF-κB pathway modulation, promotion of angiogenesis (new blood vessel formation), and acceleration of myocardial cell migration in cardiac repair models.
TB-500 Research Dosage Protocols
In published preclinical studies, TB-500 has been administered using varying protocols depending on the research objective. The most frequently referenced dosage range in rodent studies is 2–6 mg per kilogram of body weight administered 2–3 times per week.
| Phase | Frequency | Notes |
|---|---|---|
| Loading | 2–3x/week × 4–6 weeks | Higher frequency used in acute injury models |
| Maintenance | 1–2x/week × 4–6 weeks | Studied in chronic inflammation models |
TB-500 Half-Life
The pharmacokinetic profile of TB-500 has been characterized in rodent studies. Subcutaneous administration results in a relatively long half-life estimated at approximately 30 minutes to several hours depending on the model, with tissue retention extending considerably longer due to binding to actin in local tissues.
TB-500 vs BPC-157: Key Research Differences
Both TB-500 and BPC-157 are frequently studied for tissue repair signaling, but they differ in mechanism and tissue targets. BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice, and it primarily acts through nitric oxide and growth hormone receptor pathways.
TB-500 acts primarily via actin binding and upregulation of cell migration. Some researchers hypothesize that the two peptides may have complementary mechanisms, which has led to interest in combination protocols in preclinical settings — though no clinical trials have investigated this pairing.
Reconstituting TB-500 for Research
TB-500 is typically supplied as a lyophilized (freeze-dried) powder and requires reconstitution with bacteriostatic water prior to use. Standard reconstitution involves adding 1–2 mL of bacteriostatic water per 5 mg vial, yielding a concentration of 2.5–5 mg/mL.
Reconstituted TB-500 should be stored at 2–8°C and used within 30 days. Avoid repeated freeze-thaw cycles, which can degrade peptide integrity. For longer-term storage of lyophilized powder, −20°C is recommended.
Where Researchers Source TB-500
For research use, purity and accurate concentration are critical to obtaining reproducible results. Third-party tested suppliers that provide certificates of analysis (COA) with HPLC and mass spectrometry data are the standard in legitimate research settings. Prax Peptides’ TB-500 is independently tested for ≥99% purity with full COA documentation available for each batch.
Summary
TB-500 remains one of the most researched peptides in the tissue repair and regeneration space. Its unique mechanism of action via actin binding distinguishes it from other peptides under study, and its preclinical profile has made it a staple in many research programs. Researchers evaluating TB-500 should prioritize verified-purity sources and adhere to established reconstitution best practices.
⚠️ Research Use Only: All compounds referenced on this site are intended strictly for laboratory research purposes. They are not approved for human use or consumption by the FDA or any regulatory authority. This content is for informational purposes only and does not constitute medical advice.